Search Results - "Morán, María A"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Neuronal Induction of the Immunoproteasome in Huntington's Disease by Diaz-Hernandez, Miguel, Hernandez, Felix, Martin-Aparicio, Ester, Gomez-Ramos, Pilar, Moran, Maria A, Castano, Jose G, Ferrer, Isidro, Avila, Jesus, Lucas, Jose J

    Published in The Journal of neuroscience (17-12-2003)
    “…Huntington's disease (HD) inclusions are stained with anti-ubiquitin and anti-proteasome antibodies. This, together with proteasome activity studies on…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain by Díaz‐Hernández, Miguel, Valera, Adriana G., Morán, María A., Gómez‐Ramos, Pilar, Alvarez‐Castelao, Beatriz, Castaño, José G., Hernández, Félix, Lucas, José J.

    Published in Journal of neurochemistry (01-09-2006)
    “…In Huntington's disease (HD), as in the rest of CAG triplet‐repeat disorders, the expanded polyglutamine (polyQ)‐containing proteins form intraneuronal…”
    Get full text
    Journal Article
  4. 4

    Full Motor Recovery Despite Striatal Neuron Loss and Formation of Irreversible Amyloid-Like Inclusions in a Conditional Mouse Model of Huntington's Disease by Diaz-Hernandez, Miguel, Torres-Peraza, Jesus, Salvatori-Abarca, Alejandro, Moran, Maria A, Gomez-Ramos, Pilar, Alberch, Jordi, Lucas, Jose J

    Published in The Journal of neuroscience (19-10-2005)
    “…The primary mechanism responsible for Huntington's disease remains unknown. Postulated early pathogenic events include the following: impaired protein folding,…”
    Get full text
    Journal Article
  5. 5

    Biochemical, Ultrastructural, and Reversibility Studies on Huntingtin Filaments Isolated from Mouse and Human Brain by Diaz-Hernandez, Miguel, Moreno-Herrero, Fernando, Gomez-Ramos, Pilar, Moran, Maria A, Ferrer, Isidro, Baro, Arturo M, Avila, Jesus, Hernandez, Felix, Lucas, Jose J

    Published in The Journal of neuroscience (20-10-2004)
    “…Huntington's disease (HD) and eight additional inherited neurological disorders are caused by CAG triplet-repeat expansions leading to expanded…”
    Get full text
    Journal Article
  6. 6

    Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice by Lucas, José J., Hernández, Félix, Gómez-Ramos, Pilar, Morán, María A., Hen, René, Avila, Jesús

    Published in The EMBO journal (15-01-2001)
    “…Glycogen synthase kinase‐3β (GSK‐3β) has been postulated to mediate Alzheimer's disease tau hyperphosphorylation, β‐amyloid‐induced neurotoxicity and…”
    Get full text
    Journal Article
  7. 7

    GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus by Sirerol-Piquer, MaSalomé, Gomez-Ramos, Pilar, Hernández, Félix, Perez, Mar, Morán, María A., Fuster-Matanzo, Almudena, Lucas, José J., Avila, Jesús, García-Verdugo, Jose Manuel

    Published in Hippocampus (01-08-2011)
    “…Overexpression of GSK3β in transgenic mice induces learning deficits and some features associated with Alzheimer's disease (AD), including dentate gyrus (DG)…”
    Get full text
    Journal Article
  8. 8

    Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration by Engel, Tobias, Lucas, José J., Gómez-Ramos, Pilar, Moran, María A., Ávila, Jesús, Hernández, Félix

    Published in Neurobiology of aging (01-09-2006)
    “…Here we have tested whether tau modification either by point mutation or by hyperphosphorylation can exert maximal pathogenic effects or if, on the contrary,…”
    Get full text
    Journal Article
  9. 9

    Decreased nuclear [beta]-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3[beta] conditional transgenic mice by Lucas, José J, Hernández, Félix, Gómez-Ramos, Pilar, Morán, María A, Hen, René, Avila, Jesús

    Published in The EMBO journal (15-01-2001)
    “…Glycogen synthase kinase-3β (GSK-3β) has been postulated to mediate Alzheimer's disease tau hyperphosphorylation, β-amyloid-induced neurotoxicity and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients by Ulloa, L, Montejo de Garcini, E, Gómez-Ramos, P, Morán, M A, Avila, J

    Published in Brain research. Molecular brain research. (01-10-1994)
    “…Alzheimer's disease results in the appearance of cytoskeletal disorders yielding pathological structures such a neurofibrillary tangles or dystrophic neurites…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration by Engel, Tobias, Lucas, José J, Gómez-Ramos, Pilar, Moran, María A, Avila, Jesús, Hernández, Félix

    Published in Neurobiology of aging (01-09-2006)
    “…Here we have tested whether tau modification either by point mutation or by hyperphosphorylation can exert maximal pathogenic effects or if, on the contrary,…”
    Get full text
    Journal Article
  14. 14

    Decreased nuclear b-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3b conditional transgenic mice by Lucas, Jose J, Hernandez, Felix, Gomez-Ramos, Pilar, Moran, Maria A, Hen, Rene, Avila, Jesus

    Published in The EMBO journal (15-01-2001)
    “…Glycogen synthase kinase-3b (GSK-3b) has been postulated to mediate Alzheimer's disease tau hyperphosphorylation, b-amyloid-induced neurotoxicity and…”
    Get full text
    Journal Article